|
|
|
|
||
Press Release: Novavax Announces Updates to Leadership Team02-Jul-2020 08:30AM, Press Release: Novavax Announces Updates to Leadership Team Novavax Announces Updates to Leadership Team Frank Czworka appointed SVP, Global Sales Brian Webb promoted to SVP, Manufacturing GAITHERSBURG, Md., July 02, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the appointment of Frank Czworka as Senior Vice President, Global Sales, with responsibility for leading sales planning and distribution. Novavax also announced the promotion of Brian Webb to Senior Vice President, Manufacturing, with responsibility for overseeing antigen manufacturing and supply activities in support of Novavax' vaccine candidates. "Frank's extensive commercial and sales expertise will be invaluable to Novavax' transformation into a commercial stage organization," said Stanley C. Erck, President and Chief Executive Officer of Novavax. "Brian has been instrumental in the recent expansion and alignment of our manufacturing capabilities and supply partnerships. I am confident that the company will benefit greatly from their mutual expertise as we advance our efforts to bring NVX--CoV2373 and NanoFlu to market." Mr. Czworka brings more than two decades of biopharmaceutical experience to Novavax, most recently serving as Vice President, Global Customer Engagement at U.S. Pharmacopeia. In sales and marketing leadership positions at Osiris Therapeutics, Auxilium Pharmaceuticals, MedImmune and TAP Pharmaceuticals, Mr. Czworka has assembled, developed, deployed and directed award-winning global sales and marketing teams to achieve business objectives. He has launched multiple medications across a variety of therapeutic areas while increasing patient access to vital treatments. Mr. Czworka received a bachelor of science degree in business administration -- marketing from the University of Central Florida. "This is an exciting time to join Novavax, with much to be accomplished as we advance our COVID-19 candidate and prepare the regulatory submission for NanoFlu," said Mr. Czworka. "I'm excited to contribute to the team so that we can positively impact the lives of patients and reduce the global burden of these infectious diseases." Mr. Webb joined Novavax in May 2014 with responsibility for internal and external manufacturing. Prior to joining Novavax, Mr. Webb held numerous operational leadership roles at GlaxoSmithKline and Human Genome Sciences where he had the opportunity to take multiple products from early clinical stage through licensure and launch. He received a bachelor of science degree in biology from Salisbury University and a master of science degree in biotechnology from Johns Hopkins University. |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
84627 | Re: Press Release: Novavax Announces Updates to Leadership Team, Yet another MedImmune vet | scotttk | 2 | 7/2/2020 8:37:42 AM |